RELAPSED ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to beat tough leukemia
Disease control Recruiting nowThis study tests a new combination of drugs for people with acute myeloid leukemia (AML) and related blood cancers. The treatment adds a targeted drug called venetoclax to a standard chemotherapy regimen (CLAG-M). The goal is to find the safest dose and see if the combo can bette…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for kids with relapsed leukemia: experimental drug combo enters safety trial
Disease control Recruiting nowThis early-stage study tests whether adding a new drug called revumenib to two standard chemotherapy drugs is safe for children and young adults whose acute myeloid leukemia (AML) has not responded to treatment or has returned. About 24 participants will receive the three-drug co…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
New hope for relapsed leukemia: IMAGINE trial tests Triple-Drug attack
Disease control Recruiting nowThis early-phase trial is testing whether adding the experimental drug imetelstat to standard chemotherapy (azacitidine, with or without venetoclax) can safely help people whose acute myeloid leukemia has returned or not responded to prior treatment. The study involves up to 36 a…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC